Colorectal Cancer Clinical Trials in High Point, NC

Colorectal Cancer Clinical Trials in High Point, NC

View the best 10 colorectal cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in High Point, North Carolina

Here are the top 10 medical studies for colorectal cancer in High Point, North Carolina

Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of a new drug, sotorasib, to see if it can help people with a certain type of colorectal cancer that has come back after treatment.
Image of Yale University Cancer Center in New Haven, United States.

GEN1042

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial will test how safe and effective GEN1042 is in treating patients with metastatic or locally advanced solid tumors.
Image of University of Alabama at Birmingham in Birmingham, United States.

Minnelideā„¢ Capsules

Anti-tumor antibiotic

Recruiting1 awardPhase 1
This trial is testing a new drug, Minnelide, to see if it is safe and effective for treating patients with advanced solid tumors.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is designed to study the effects of a new drug, selpercatinib, on various types of solid tumors. The goal is to see if it is safe and tolerable, how it is metabolized, and if it has any preliminary anti-tumor activity.
Image of Duke Cancer Institute in Durham, United States.

mHealth Coping Skills Training for Symptom Management (mCOPE)

Behavioral Intervention

Recruiting1 award4 criteria
This trial is testing whether an app can help young and middle-aged colorectal cancer patients with pain, fatigue, and distress. The app would teach patients coping skills and provide personalized real-time feedback.
Image of SWOG in Portland, United States.

Cetuximab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing whether adding nivolumab to the usual treatment of encorafenib and cetuximab works better at shrinking tumors in patients with colorectal cancer that has spread or cannot be removed by surgery.
Image of UCLA Medical Center in Los Angeles, United States.

IDE196

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial is testing the safety and effectiveness of a new drug, IDE196, for patients with solid tumors that have a specific gene mutation. The trial has three parts. First, they will test different doses of the drug to see what is safe and what the side effects are. Second, they will test the drug combination with binimetinib to see if it is effective and has any new side effects. Third, they will test the drug combination with crizotinib to see if it is effective and has any new side effects.
Image of University of Michigan Rogel Cancer Center in Ann Arbor, United States.

TPST-1495 +1 More

Small Molecule

Recruiting1 awardPhase 1
This trial is testing a new drug, TPST-1495, to see if it is safe and effective in treating subjects with advanced solid tumors. The study will also look at the side effects of the drug and how it works in the body.
Image of Dignity Health St Joseph's Hospital and Medical Center in Phoenix, United States.

Entrectinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, entrectinib, for patients with different types of solid tumors that have a gene fusion. Patients will be assigned to different groups depending on their tumor type and gene fusion.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.

Popular filter options for colorectal-cancer high-point trials

Phase 3 Clinical Trials

View 74 phase 3 medical studies.

Clinical Trials With No Placebo

View 74 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.